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COVID-19 affects us all but its toll is not equal. Consistent evidence globally has 
highlighted greater COVID-19 severity with older age, male sex, obesity, and co-
morbidities1,2. Early data suggested that people of Black, Asian and Minority Ethnic 
(BAME) groups in the UK and Black, Hispanic and Native American groups in the US were 
disproportionately affected by severe COVID-19 complication and deaths3,4.  
 
Initial descriptive data from the Intensive Care National Audit and Research Centre 
indicated that over 30% of people admitted to intensive care in the UK came from BAME 
groups despite them comprising around 13% of the of the UK population5. Blacks in the 
US, who represent 13.4% of the nation, account for around 60% of deaths and in 
predominantly Black communities experience a 6-fold risk of infection6. In New Mexico, 
Native Americans account for 11% of the population but 37% of COVID-19 positive 
cases4.  Stark differences also extend to healthcare staff.  Within the UK National Health 
Service, 21 % of staff are from BAME backgrounds but they account for 63% of deaths7. In 
the US, Blacks account for over 20% of COVID-19 cases among health professionals 
despite only 5% of doctors and 10% nurses in the US being Blacks8,9.  
 
The extent to which known or unknown factors contribute to the greater COVID-19 burden 
or severity in BAME people is not known3.  Research efforts have commenced including 
randomised trials of treatments and preventive vaccines as well as observational and other 
studies and it is vital that such research should include representative samples of people 
with BAME backgrounds. This is not guaranteed.    
 
Past evidence indicates that BAME individuals are under-represented in research10,11. For 
instance, in the UK, type 2 diabetes is disproportionately prevalent in BAME groups with 
poorer long-term outcomes but in a review of 12 trials, the mean South Asian involvement 
was 5.5% despite South Asians representing 11.2% of the UK type 2 diabetes 
population12.  Four of the 12 studies didn’t even report ethnicity. Similar results for South 
Asians are seen in the US13.   This lack of attention to ethnicity is being mirrored in 
COVID-19 research.  Of 1518 COVID-19 studies registered on ClinicalTrials.gov, only six 
studies are currently collecting data on ethnicity14.  
 
The reasons for under-representation of BAME groups are complex. They may be 
attributable to participants, healthcare staff or researchers or societal factors, and range 
from non-participation to exclusion, mostly inadvertent but sometimes by design. Barriers 
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to participation include language difficulties, lack of research awareness or mistrust of 
research, stigma, cultural values and beliefs about research, poor engagement from 
researchers and general inaccessibility to research in deprived areas, including concerns 
of costs of time and money15.  
 
A decision to limit trial materials to English, for example, means over 40% of Bangladeshi 
women and over 30% of Pakistani women aged over 65 in the UK will not understand it16.  
A recent American Community Survey found that 21.9% of the US populations spoke a 
language other than English at home, with Spanish dominating17.  And written translation 
is just the start.  Native speakers may be needed and recruitment is likely to need tailored 
approaches.  Cultural issues, for example, may mean that information needs to be 
provided to families by someone trusted rather than by an unknown member of healthcare 
staff. These factors will therefore increase costs for these studies and will need to be 
considered by funders.  
 
The National Institutes for Health in the US has mandated inclusion of BAME groups since 
1994 although reporting is generally limited to White, Hispanic or Latino18.  There is no 
obligation to record ethnicity in research studies in the UK.  The UK’s National Institute for 
Health Research initiated the INCLUDE project in 2018 to widen inclusion of many under-
served groups, including BAME19.  Its work on BAME involvement will recommend that 
researchers think carefully about who their research results must apply to and that they do 
all they can to make sure that relevant BAME groups are involved.  There are exemplars 
and best practice toolkits to help researchers to engage, inform and recruit BAME 
participants to research20.  We need to use them.  
 
COVID-19 is shining a spotlight on a problem that has been with us for a long time.  
Results from COVID-19 research must apply to everyone in the community who will be a 
candidate for treatment or prevention, and people of BAME groups– often overrepresented 
in the toll of the disease –should be an integral part of that effort. Omission has 
consequences: people could miss out on important benefits, or not be spared harms, if 
research fails to engage all those who could benefit: there is no guarantee that results will 
apply to populations not included in the research.  
 
For BAME involvement in research to improve, thinking about participants’ ethnicity when 
designing and reporting research needs to become as routine as thinking about their age 
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and sex.  Researchers, research funders, public health and policy agencies all have a duty 
to ensure that concerted action is taken for research studies to serve and represent the 
whole community not just part of it.   
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